Skip to content

NUGENEREX IMMUNO-ONCOLOGY, INC.

company.status.inactive

CIK 1804585fmd_1739YSZ6KVBGJ8B1BDNPV8AYHYManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Aug 01, 2018 to Apr 30, 2021, 11 periods

Ratios computed from the standardized statements. Select a value to open its proof.

Loading